The Cassava Sciences stock (NASDAQ: SAVA) has been very bullish over the past month. It has gained more than 58% in a span of 30 days and investors are still bullish on the stock.
Yesterday, a whale with a lot of money to spend took a noticeably bullish stance on the SAVA stock. Besides the whale, the majority of traders have opened call positions on the SAVA stock compared to put options hinting at how optimistic investors are about the stock.
To help stock investors who want to invest in the SAVA stock, Invezz has created a brief guide on where they can buy it.
To find out more, please continue reading.
Where to buy Cassava Sciences stock
eToro is a multi-asset investment platform with more than 2000 assets, including FX, stocks, ETF’s, indices and commodities. eToro users can connect with, learn from, and copy or get copied by other users. Buying stocks on eToro is free and you can invest with as little as $50.
Investoo Ltd is compensated if you access certain of the products or services offered by eToro USA LLC and/or eToro USA Securities Inc., as applicable. This compensation incentivizes Investoo Ltd to describe those products and services in favorable terms. Any testimonials contained in this communication may not be representative of the experience of other eToro customers and such testimonials are not guarantees of future performance or success.
The world-leading online trading and investments provider giving clients access to opportunities across thousands of financial markets through our intuitive platforms and apps.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
What is Cassava Sciences?
Cassava Sciences is a clinical-stage biotechnology company that develops drugs for neurodegenerative diseases like Alzheimer’s. It was previously known as Pain Therapeutics, Inc.
Its top therapeutic products include simufilam, which is a small molecule drug, and SavaDx, which is a blood-based diagnostic drug for detecting Alzheimer’s disease.
It is a publicly-traded company and it trades on Nasdaq, under the ticker SAVA. Nasdaq recently announced that it is starting to offer crypto custody via its new Digital Assets unit.
Should I buy the SAVA stock today?
If you are looking to take advantage of a stock whose price has largely gained over the past month, then the SAVA stock could be a good choice.
However, it is still not clear how far the current bull trend will go.
Cassava Sciences stock price prediction
Based on a forecast from several stock analysts, the SAVA stock is expected to continue rising in the coming days and possibly surge above $40 by the end of this week.
$SAVA social media trends
The post Whales go bullish on SAVA stock: where to buy the Cassava Sciences stock appeared first on Invezz.